SCHEMBL20913919

SCHEMBL20913919

Cc1[nH]c2c(-c3ccccc3)c(C(F)(F)F)nn2c(=O)c1-c1nc2c(O)cccc2o1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ARF6 P62330 7/20 0.42
▸ POLB P06746 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TNKS O95271 2/20 0.33
▸ PARP1 P09874 2/20 0.33
▸ TNKS2 Q9H2K2 2/20 0.33
▸ F2RL3 Q96RI0 1/20 0.33
▸ PDGFRA P16234 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ CASR P41180 1/20 0.32
▸ PLAT P00750 1/20 0.31
▸ TOP2A P11388 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914411 0.91 POLB (0.39) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20914004 0.90 POLB (0.39) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20913961 0.89 POLB (0.38) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20914121 0.89 ARF6 (0.38) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20914293 0.89 KDM4E (0.37) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20913899 0.88 POLB (0.38) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20914337 0.88 POLB (0.37) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20914097 0.88 POLB (0.37) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20914210 0.88 POLB (0.37) ARF6POLBKDM4EMEN1ALDH1A1
SCHEMBL20819069 0.88 TNKS (0.37) ARF6POLBKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 ARF6 3310/4885POLB 4311/4885KDM4E 1922/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 ARF6 3310/4885POLB 4311/4885KDM4E 1922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback